9780521876629 - Molecular Oncology: Causes of Cancer and Targets for Treatment von Edward P. Gelmann , Charles L. Sawyers , Frank J. Rauscher III (5 Ergebnisse)

Zustand: Very Good. Very Good+; Hardcover; Covers are still glossy; Unblemished textblock edges; The endpapers and all text pages are clean and unmarked; Tight binding; This book will be stored and delivered in a sturdy cardboard box with foam padding; Large Format (Quatro, 10.75" - 11.75" tall); Heavy (6.5 lbs); Dark green/black covers with title in green lettering; 2014, Cambridge University Press; 979 pages; "Molecular Oncology: Causes of Cancer and Targets for Treatment," by Edward P. Gelmann, et al.

Zustand: New. In.

Hardcover. Zustand: Brand New. 1st edition. 961 pages. 12.00x10.00x2.00 inches. In Stock.

Zustand: New. Reviews the origins of molecular oncology, including technologies for cancer analysis, key pathways in human malignancies, and available pharmacologic therapies. Editor(s): Gelman, Edward P.; Sawyers, Charles L.; Rauscher, Frank J. Num Pages: 979 pages, 48 b/w illus. 317 colour illus. 91 tables. BIC Classification: MJCL. Category: (U) Tertiary Education (US: College). Dimension: 279 x 225 x 44. Weight in Grams: 2966. . 2014. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been discovered that are critical drivers of large cross-sections of human cancers. These discoveries have allowed us to find drugs that target these drivers and make important strides in treatment. Genomics and high-throughput technologies have illuminated the complexity of cancer and the facility with which cancers adapt during their natural history. The field is evolving rapidly with new discoveries and new drugs reported monthly. This book is a timely foundation for understanding in context the origins of molecular oncology and its future directions. The content reviews available technologies for the analysis of cancer tissues and genes; summaries of key oncogenic pathways from a molecular perspective; the technologies, pathways and targeted therapies of a wide range of human malignancies; and new pharmacologic therapies that have a common mechanistic target.